The Impact of Bariatric Procedures on the Efficacy of Capecitabine for the Management of Colorectal Cancer
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
References
1.
Lau C, Mohmaed Ali M, Lin L, van Balen D, Jacobs B, Nuijen B
. Impact of bariatric surgery on oral anticancer drugs: an analysis of real-world data. Cancer Chemother Pharmacol. 2024; 94(1):25-34.
PMC: 11258081.
DOI: 10.1007/s00280-024-04640-0.
View
2.
Goldberg S
. Bariatric surgery and oral chemotherapy: Where is the dosing guidance?. Cancer. 2023; 129(12):1800-1802.
DOI: 10.1002/cncr.34721.
View
3.
Steenackers N, Vanuytsel T, Augustijns P, Tack J, Mertens A, Lannoo M
. Adaptations in gastrointestinal physiology after sleeve gastrectomy and Roux-en-Y gastric bypass. Lancet Gastroenterol Hepatol. 2021; 6(3):225-237.
DOI: 10.1016/S2468-1253(20)30302-2.
View
4.
DAmato S, Sofia M, Agosta M, Litrico G, Sarva I, La Greca G
. The impact of bariatric surgery on colorectal cancer risk. Surg Obes Relat Dis. 2022; 19(2):144-157.
DOI: 10.1016/j.soard.2022.10.016.
View
5.
Bland C, Quidley A, Love B, Yeager C, McMichael B, Bookstaver P
. Long-term pharmacotherapy considerations in the bariatric surgery patient. Am J Health Syst Pharm. 2016; 73(16):1230-42.
DOI: 10.2146/ajhp151062.
View